Corcept Therapeutics | CORT - Trade Debtors


Corcept Therapeutics reported $59.79M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Ardelyx USD 76.61M 14.06M Sep/2025
Assertio Holdings USD 39.91M 2.7M Jun/2024
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Corcept Therapeutics USD 59.79M 9.84M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
J&J USD 17.61B 235M Sep/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Lexicon Pharmaceuticals USD 2.62M 1.09M Jun/2024
Merck USD 12.12B 596M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Novartis USD 8.98B 192M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 115.27M 901K Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025